Cargando…
Are Hematologic Patients Trojan Horse for COVID-19?
Coronavirus disease 2019 (COVID-19) which is caused by severe acute respiratory distress syndrome virus (SARS-CoV-2) continues to affect people all around the world. This study aimed to compare the SARS-CoV-2 viral shedding time between patients diagnosed with hematologic diseases (HD) and a control...
Autores principales: | Kılıçaslan, Emrah, Erdoğan Özünal, Işıl, Elibol, Tayfun, Öztürk, Erman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517942/ https://www.ncbi.nlm.nih.gov/pubmed/34667375 http://dx.doi.org/10.1007/s12288-021-01498-7 |
Ejemplares similares
-
Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma
por: OZTURK, Erman, et al.
Publicado: (2022) -
A Rare Side Effect of Ibrutinib: Tumor Lysis Syndrome
por: Ozturk, Erman, et al.
Publicado: (2021) -
Macrophages and Monocytes: “Trojan Horses” in COVID-19
por: Percivalle, Elena, et al.
Publicado: (2021) -
Macrophages: a Trojan horse in COVID-19?
por: Park, Matthew D.
Publicado: (2020) -
Invisible Trojan-horse attack
por: Sajeed, Shihan, et al.
Publicado: (2017)